Development of Special Biological Products

Development of Special Biological Products

Contents: Rift Valley Fever (RVF) Vaccine Development; Rift Valley Fever (RVF) HA Antigen; Rift Valley Fever (RVF) SA-51 Virus Strain; Vee Vaccine Development; WEE Vaccine Development, Chikungunya Vaccine Development; Q Fever Program; Rocky Mountain Spotted Fever; Tissue Culture; and Inventory of Va...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: DeSanctis, Armand N, DeMeio, Joseph L, Craig, Donald E, Spicer, Daniel S, Thomas, William J
Format: Report
Sprache:eng
Schlagworte:
ANTIGENS
AS841
BIOLOGICAL PRODUCTS
INVENTORY
LABORATORY ANIMALS
Medicine and Medical Research
PE62776A
Pharmacology
PREPARATION
PRODUCTION
Q FEVER
RIFT VALLEY FEVER
STRAINS(BIOLOGY)
TEST METHODS
TISSUE CULTURE
VACCINES
WESTERN EQUINE ENCEPHALOMYELITIS VIRUS
WU081
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Contents: Rift Valley Fever (RVF) Vaccine Development; Rift Valley Fever (RVF) HA Antigen; Rift Valley Fever (RVF) SA-51 Virus Strain; Vee Vaccine Development; WEE Vaccine Development, Chikungunya Vaccine Development; Q Fever Program; Rocky Mountain Spotted Fever; Tissue Culture; and Inventory of Vaccines (1978).